Stock-based Awards | Stock-based Awards Stock Options A summary of the Company’s stock option activity for the three months ended March 31, 2024 is as follows: Number of Weighted-Average Exercise Price Weighted-Average (in years) Outstanding at December 31, 2023 2,240,898 $ 10.65 3.1 Granted — — Exercised — — Forfeited/expired (299,093) 11.56 Outstanding at March 31, 2024 1,941,805 $ 10.51 3.1 At March 31, 2024, total remaining stock-based compensation expense for unvested stock option awards was $0.2 million, which is expected to be recognized over a weighted-average period of 1.0 year. For the three months ended March 31, 2024 and 2023, the Company recorded stock-based compensation expense for stock option awards of $0.1 million and $0.3 million, respectively. Restricted Stock Units Activity in connection with restricted stock units is as follows for the three months ended March 31, 2024: Number of Weighted- Average Grant Date Fair Value Non-vested — December 31, 2023 5,763,510 $ 2.94 Granted 2,749,085 3.54 Vested (454,020) 3.46 Forfeited (423,586) 3.28 Non-vested — March 31, 2024 7,634,989 $ 3.11 At March 31, 2024, total remaining stock-based compensation expense for non-vested restricted stock units was $21.9 million, which is expected to be recognized over a weighted-average period of 3.0 years. For the three months ended March 31, 2024 and 2023, the Company recorded $1.8 million and $3.2 million in stock-based compensation expense for restricted stock units, respectively. Performance Stock Units Activity in connection with performance stock units is as follows for the three months ended March 31, 2024: Number of Weighted- Average Grant Date Fair Value Outstanding — December 31, 2023 2,518,556 $ 4.18 Granted 1,231,577 4.39 Vested (364,837) 5.99 Forfeited (131,555) 5.25 Outstanding — March 31, 2024 3,253,741 $ 4.01 At March 31, 2024, total remaining stock-based compensation expense for non-vested performance stock units was $7.9 million, which is expected to be recognized over a weighted-average period of 2.5 years. For the three months ended March 31, 2024 and 2023, the Company recorded $0.7 million and $1.2 million in stock-based compensation expense for performance stock units, respectively. Stock-based Compensation Cost The Company recorded stock-based compensation cost relating to stock options, restricted stock units, and performance stock units in the following categories on the accompanying condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended 2024 2023 Cost of revenue $ 52 $ 50 Sales and marketing 399 1,895 Technology and development 496 1,017 General and administrative 1,685 1,746 Total stock-based compensation expense 2,632 4,708 Amount capitalized to internal software use 190 222 Total stock-based compensation cost $ 2,822 $ 4,930 |